CUMULATIVE RESULTS
Cumulative results from isolates from all hospitals of the network are presented.
Only the first isolate per patient and species is being processed.
(* List of Abbreviations and Acronyms Used in the Tables)

July - December 2022
PERCENT (%) RESISTANCE
TO SELECTED ANTIBIOTICS BY HOSPITAL
 
Acinetobacter baumannii
  Amikacin (all clinical specimens)
  Ciprofloxacin (all clinical specimens)
  Imipenem (all clinical specimens)
  Colistin (all clinical specimens)
Pseudomonas aeruginosa
  Amikacin (all clinical specimens)
  Ceftazidime (all clinical specimens)
  Ciprofloxacin (all clinical specimens)
  Imipenem (all clinical specimens)
  Piperacillin/Tazobactam (all clinical specimens)
Enterobacter spp
  Tobramycin (all clinical specimens)
  Ceftazidime (all clinical specimens)
  Ciprofloxacin (all clinical specimens)
  Imipenem (all clinical specimens)
  Cefepime (all clinical specimens)
  Piperacillin/Tazobactam (all clinical specimens)
Staphylococcus aureus
  MRSA (all clinical specimens)
Klebsiella pneumoniae
   Ceftazidime (all clinical specimens)
  Ciprofloxacin (all clinical specimens)
  Imipenem (all clinical specimens)
  Cefepime (all clinical specimens)
  Tobramycin (all clinical specimens)

Piperacillin/Tazobactam (all clinical specimens)
Proteus mirabilis
  Ceftazidime (all clinical specimens)
  Ciprofloxacin (all clinical specimens)
  Cefepime (all clinical specimens)
  Tobramycin (all clinical specimens)
  Piperacillin/Tazobactam (all clinical specimens)
Enterococcus spp
  Gentamicin (all clinical specimens)
  Vancomycin (all clinical specimens)
Escherichia coli
  Ciprofloxacin (all clinical specimens)

Piperacillin/Tazobactam (all clinical specimens)

Ceftazidime (all clinical specimens)